Cited by 552Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Trans-cellular Propagation of Tau Aggregation by Fibrillar Species

Open access

Kfoury, Najla, Holmes, Brandon B., Jiang, Hong, Holtzman, David M., Diamond, Marc I.·2012·Journal of Biological Chemistry

DOI 10.1074/jbc.m112.346072PMC PMC3365982

Open this paper in CoChat — free account Open PDF

Abstract

Aggregation of the microtubule associated protein Tau is associated with several neurodegenerative disorders, including Alzheimer disease and frontotemporal dementia. In Alzheimer disease, Tau pathology spreads progressively throughout the brain, possibly along existing neural networks. However, it is still unclear how the propagation of Tau misfolding occurs. Intriguingly, in animal models, vaccine-based therapies have reduced Tau and synuclein pathology by uncertain mechanisms, given that these proteins are intracellular. We have previously speculated that trans-cellular propagation of misfolding could be mediated by a process similar to prion pathogenesis, in which fibrillar Tau aggregates spread pathology from cell to cell. However, there has been little evidence to demonstrate true trans-cellular propagation of Tau misfolding, in which Tau aggregates from one cell directly contact Tau protein in the recipient cell to trigger further aggregation. Here we have observed that intracellular Tau fibrils are directly released into the medium and then taken up by co-cultured cells. Internalized Tau aggregates induce fibrillization of intracellular Tau in these naive recipient cells via direct protein-protein contact that we demonstrate using FRET. Tau aggregation can be amplified across several generations of cells. An anti-Tau monoclonal antibody blocks Tau aggregate propagation by trapping fibrils in the extracellular space and preventing their uptake. Thus, propagation of Tau protein misfolding among cells can be mediated by release and subsequent uptake of fibrils that directly contact native protein in recipient cells. These results support the model of aggregate propagation by templated conformational change and suggest a mechanism for vaccine-based therapies in neurodegenerative diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m112.346072

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 201–300 of 546

A dip-and-read optical aptasensor for detection of tau protein
Ziu, I., Laryea, E. T., Alashkar, F., Wu, C. G., & Martić, S. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02350-8 · Cited by 58
Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease
Ghosh, S., Durgvanshi, S., Agarwal, S., Raghunath, M., & Sinha, J. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200429011823 · Cited by 57
Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!
Nelson, L., Gard, P., & Tabet, N. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140024 · Cited by 59
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
Oakley, S. S., Maina, M. B., Marshall, K. E., Al‐Hilaly, Y. K., Harrington, C., Wischik, C. M., & Serpell, L. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590754 · Cited by 59
Cholesterol determines the cytosolic entry and seeded aggregation of tau
Tuck, B. J., Miller, L. V. C., Katsinelos, T., Smith, A. E., Wilson, E. L., Keeling, S., Cheng, S., Vaysburd, M. J., Knox, C., Tredgett, L., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110776 · Cited by 57
Mechanistic Studies Unravel the Complexity Inherent in Tau Aggregation Leading to Alzheimer’s Disease and the Tauopathies
Ramachandran, G., & Udgaonkar, J. B. (2013) · Biochemistry · doi:10.1021/bi400209z · Cited by 59
Brain Somatic Mutation in Aging and Alzheimer's Disease
Miller, M. B., Reed, H., & Walsh, C. A. (2021) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-121520-081242 · Cited by 57
Primary cilia and autophagic dysfunction in Huntington’s disease
Kaliszewski, M., Knott, A. B., & Bossy-Wetzel, E. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.80 · Cited by 55
Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy
Congdon, E. E., Chukwu, J. E., Shamir, D. B., Deng, J., Ujla, D., Sait, H. B. R., Neubert, T. A., Kong, X., & Sigurdsson, E. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.033 · Cited by 56
Beyond amyloid: Getting real about nonamyloid targets in Alzheimer's disease
Herrup, K., Carrillo, M. C., Schenk, D., Cacace, A. M., DeSanti, S., Fremeau, R. T., Bhat, R. V., Glicksman, M. A., May, P. C., Swerdlow, R. H., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.017 · Cited by 55
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
Ayubcha, C., Revheim, M.-E. R., Newberg, A. B., Moghbel, M. C., Rojulpote, C., Werner, T. J., & Alavi, A. A. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04926-4 · Cited by 56
Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases
Kim, M., Calì, I., Oehler, A., Fong, J. C., Wong, K., See, T. M., Katz, J., Gambetti, P. L., Bettcher, B. M., DeArmond, S. J., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-80 · Cited by 53
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
Agadjanyan, M. G., Zagorski, K., Petrushina, I., Davtyan, H., Kazarian, K., Antonenko, M., Davis, J. L., Bon, C., Blurton-Jones, M. M., Cribbs, D. H., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0172-1 · Cited by 56
Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans
Weisová, P., Cehlár, O., Škrabana, R., Žilková, M., Filipčík, P., Kováčech, B., Prčina, M., Wojčiaková, Ľ., Fialová, Ľ., Smolek, T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0770-y · Cited by 53
Neurodegenerative Disorders
Yacoubian, T. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00001-5 · Cited by 56
MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates
Nagahara, A. H., Wilson, B. R., Ivasyk, I., Kovács, I., Rawalji, S., Bringas, J. R., Pivirotto, P., Sebastián, W. S., Samaranch, L., Bankiewicz, K. S., et al. (2018) · Gene Therapy · doi:10.1038/s41434-018-0010-2 · Cited by 52
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51
How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders
Carlson, G. A., & Prusiner, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094861 · Cited by 51
Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease
Virgone‐Carlotta, A., Uhlrich, J., Akram, M. N., Ressnikoff, D., Chrétien, F., Domenget, C., Gherardi, R. K., Despars, G., Jurdic, P., Honnorat, J., et al. (2013) · Glia · doi:10.1002/glia.22546 · Cited by 52
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 58
Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of α-synuclein via exosome
Yang, Y. A., Qin, M., Bao, P., Xu, W., & Xu, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180892 · Cited by 51
Discovery and Optimization of Tau Targeted Protein Degraders Enabled by Patient Induced Pluripotent Stem Cells-Derived Neuronal Models of Tauopathy
Silva, M. C., Nandi, G., Donovan, K. A., Cai, Q., Berry, B. C., Nowak, R. P., Fischer, E. S., Gray, N. S., Ferguson, F. M., & Haggarty, S. J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.801179 · Cited by 51
Tau secretion is correlated to an increase of Golgi dynamics
Mohamed, N., Desjardins, A., & Leclerc, N. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178288 · Cited by 55
The neuronal extracellular matrix restricts distribution and internalization of aggregated Tau-protein
Suttkus, A., Holzer, M., Morawski, M., & Arendt, T. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.040 · Cited by 50
Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
Rajamohamedsait, H., Rasool, S., Rajamohamedsait, W., Lin, Y., & Sigurdsson, E. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-17313-1 · Cited by 49
Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies
Schroeder, S. K., Joly‐Amado, A., Gordon, M. N., & Morgan, D. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9637-6 · Cited by 51
How the shapes of seeds can influence pathology
Melki, R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.011 · Cited by 50
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
d’Abramo, C., Acker, C. M., Jimenez, H. T., & Davies, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135774 · Cited by 49
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 50
Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 48
CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model
Johnson, N. R., Yuan, P., Castillo, E., Lopez, T. P., Yue, W., Bond, A., Rivera, B. M., Sullivan, M. C., Hirouchi, M., Giles, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35753-w · Cited by 46
Impaired tau–microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations
Xia, Y., Sorrentino, Z. A., Kim, J. D., Strang, K. H., Riffe, C. J., & Giasson, B. I. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010178 · Cited by 48
Tau internalization: A complex step in tau propagation
Zhao, J., Wu, H., & Tang, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101272 · Cited by 47
Neuropathology of the Alzheimer's continuum: an update
Jellinger, K. A. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3050 · Cited by 52
Expanding spectrum of prion diseases
Ayers, J. I., Paras, N. A., & Prusiner, S. B. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20200037 · Cited by 45
Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers
Zamanian, J., Khoshbin, Z., Abnous, K., Taghdisi, S. M., Hosseinzadeh, H., & Danesh, N. M. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113789 · Cited by 45
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy
Forrest, S. L., Lee, S., Nassir, N., Martínez-Valbuena, I., Sackmann, V., Li, J., Ahmed, A., Tartaglia, M. C., Ittner, L. M., Lang, A. E., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02604-x · Cited by 44
TDP ‐43 in amyotrophic lateral sclerosis – is it a prion disease?
Ludolph, A. C., & Brettschneider, J. (2015) · European Journal of Neurology · doi:10.1111/ene.12706 · Cited by 45
Recent developments with tau-based drug discovery
Iqbal, K., Liu, F., & Gong, C. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1445084 · Cited by 46
Recent advancements toward therapeutic vaccines against Alzheimer’s disease
Herline, K., Drummond, E., & Wısnıewskı, T. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1500905 · Cited by 46
The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration
Katsinelos, T., Tuck, B. J., Mukadam, A. S., & McEwan, W. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01139 · Cited by 46
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
Gibbons, G. S., Kim, S., Wu, Q., Riddle, D. M., Leight, S. N., Changolkar, L. N., Xu, H. W., Meymand, E. S., O’Reilly, M., Zhang, B., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00404-5 · Cited by 45
Vaccination strategies in tauopathies and synucleinopathies
Braczynski, A. K., Schulz, J. B., & Bach, J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14207 · Cited by 44
LRRK2 Promotes Tau Accumulation, Aggregation and Release
Guerreiro, P. S., Gerhardt, E., da Fonseca, T. L., Bähr, M., Outeiro, T. F., & Eckermann, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9209-z · Cited by 46
Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
Meyer, V., Dinkel, P. D., Luo, Y., Yu, X., Wei, G., Zheng, J., Eaton, G. R., Ma, B., Nussinov, R., Eaton, S. S., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308473 · Cited by 42
Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
La‐Rocque, S. D., Moretto, E., Butnaru, I., & Schiavo, G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 46
Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice
Ding, X., Xiang, Z., Qin, C., Chen, Y., Tian, H., Lin, M., Xia, D., Liu, H., Song, J. T., Fu, J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01112-3 · Cited by 43
The Prion-Like Behavior of Assembled Tau in Transgenic MicePreprint
Clavaguera, F., Tolnay, M., & Goedert, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024372 · Cited by 45
Disruption of nuclear envelope integrity as a possible initiating event in tauopathies
Prissette, M., Fury, W., Koss, M., Racioppi, C., Fedorova, D., Dragileva, E., Clarke, G., Pohl, T., Dugan, J., Ahrens, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111249 · Cited by 41
Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34005-1 · Cited by 43
Possible Neuropathology of Sleep Disturbance Linking to Alzheimer’s Disease: Astrocytic and Microglial Roles
Xiao, S., Liu, Y.-J., Wang, L., Sha, Z., Che, X., Yu, Z., & Lee, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.875138 · Cited by 41
Tau Protein and Tauopathies: Exploring Tau Protein–Protein and Microtubule Interactions, Cross‐Interactions and Therapeutic Strategies
Lorenzo, D. D. (2024) · ChemMedChem · doi:10.1002/cmdc.202400180 · Cited by 46
Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
Schultz, M. K., Gentzel, R. C., Usenovic, M., Gretzula, C. A., Ware, C., Parmentier‐Batteur, S., Schachter, J. B., & Zariwala, H. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.003 · Cited by 45
Emerging Diagnostic and Therapeutic Strategies for Tauopathies
Coughlin, D. G., & Irwin, D. J. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0779-1 · Cited by 42
Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo
Vandermeeren, M., Borgers, M., Kolen, K. V., Theunis, C., Vasconcelos, B., Bottelbergs, A., Wintmolders, C., Daneels, G., Willems, R., Dockx, K., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180404 · Cited by 40
Retromer regulates the lysosomal clearance of MAPT/tau
Carosi, J. M., Hein, L. K., van den Hurk, M., Adams, R., Milky, B., Singh, S., Bardy, C., Denton, D., Kumar, S., & Sargeant, T. J. (2020) · Autophagy · doi:10.1080/15548627.2020.1821545 · Cited by 41
Lung endothelium, tau, and amyloids in health and disease
Balczon, R., Lin, M. T., Voth, S. B., Nelson, A. R., Schupp, J. C., Wagener, B. M., Pittet, J., & Stevens, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00006.2023 · Cited by 40
Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions
Yue, Y., Zhang, X., Lv, W., Lai, H., & Shen, T. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390970 · Cited by 38
Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
Kaufman, S. K., & Diamond, M. I. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0196-3 · Cited by 40
Self-citation
Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
Marciniuk, K., Taschuk, R., & Napper, S. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/473706 · Cited by 39
Tau proteinopathies and the prion concept
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.003 · Cited by 38
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly
Congdon, E. E., Jiang, Y., & Sigurdsson, E. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.12.002 · Cited by 38
Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19
Mir, M. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03715-y · Cited by 38
Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy
Morrow, K. A., Ochoa, C. D., Balczon, R., Zhou, C., Cauthen, L., ALEXEYEV, M. F., Schmalzer, K. M., Frank, D. W., & Stevens, T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00103.2015 · Cited by 37
Implications of mRNA translation dysregulation for neurological disorders
Jishi, A., Qi, X., & Miranda, H. C. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.09.005 · Cited by 40
Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer’s disease
Sun, G. G., Wang, C., Mazzarino, R. C., Perez-Corredor, P. A., Davtyan, H., Blurton-Jones, M., Lopera, F., Arboleda-Velasquez, J. F., & Shi, Y. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114982 · Cited by 36
Cellular mechanisms responsible for cell-to-cell spreading of prions
Vilette, D., Courte, J., Peyrin, J., Coudert, L., Schaeffer, L., Andréoletti, O., & Leblanc, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2823-y · Cited by 43
Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance
Quittot, N., Sebastiao, M., & Bourgault, S. (2017) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0236 · Cited by 39
Chronic Traumatic Encephalopathy: Is Latency in Symptom Onset Explained by Tau Propagation?Preprint
Kriegel, J., Papadopoulos, Z., & McKee, A. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024059 · Cited by 38
Effect of Mid-infrared Free-Electron Laser Irradiation on Refolding of Amyloid-Like Fibrils of Lysozyme into Native Form
Kawasaki, T., Fujioka, J., Imai, T., & Tsukiyama∥, K. (2012) · The Protein Journal · doi:10.1007/s10930-012-9452-3 · Cited by 35
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns
Asher, D. M., Belay, E. D., Bigio, E. H., Brandner, S., Brubaker, S. A., Caughey, B. W., Clark, B., Damon, I. K., Diamond, M. I., Freund, M. P., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa109 · Cited by 35
Self-citation
The E3 Ubiquitin Ligase, CHIP/STUB1, Inhibits Aggregation of Phosphorylated Proteoforms of Microtubule-associated Protein Tau (MAPT)
Nadel, C. M., Thwin, A. C., Callahan, M., Lee, K., Connelly, E. J., Craik, C. S., Southworth, D. R., & Gestwicki, J. E. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168026 · Cited by 34
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease
Davis, M. R., Robinson, E., Koronyo, Y., Salobrar‐García, E., Rentsendorj, A., Gaire, B. P., Mirzaei, N., Kayed, R., Sadun, A. A., Ljubimov, A. V., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01935-y · Cited by 34
Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach
Shamir, D. B., Rosenqvist, N., Rasool, S., Pedersen, J. T., & Sigurdsson, E. M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.013 · Cited by 34
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32
Prion-like Mechanisms in Alzheimer's Disease
Yin, R., Tan, L., Jiang, T., & Yu, J. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910121425 · Cited by 33
How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh, R. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a269b · Cited by 33
Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin
Townsend, D. J., Fullwood, N. J., Yates, E. A., & Middleton, D. A. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00443 · Cited by 32
Cytotoxic tau released from lung microvascular endothelial cells upon infection with Pseudomonas aeruginosa promotes neuronal tauopathy
Choi, C., Gwin, M. S., Voth, S. B., Kolb, C., Zhou, C., Nelson, A. R., Deweever, A., Koloteva, A., Annamdevula, N. S., Murphy, J. M., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101482 · Cited by 33
Progress Update: Fluid and Imaging Biomarkers in Alzheimer’s Disease
Sutphen, C. L., Fagan, A. M., & Holtzman, D. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.031 · Cited by 31
Self-citation
Traumatic brain injury and the pathways to cerebral tau accumulation
Flavin, W. P., Hosseini, H. C., Ruberti, J. W., Kavehpour, H. P., Giza, C. C., & Prins, M. L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1239653 · Cited by 33
Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay
Siano, G., Caiazza, M. C., Ollà, I., Varisco, M., Madaro, G., Quercioli, V., Calvello, M., Cattaneo, A., & Primio, C. D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00386 · Cited by 31
Transcellular Spreading of Tau in Tauopathies
Demaegd, K. C., Schymkowitz, J. W. H., & Rousseau, F. (2018) · ChemBioChem · doi:10.1002/cbic.201800288 · Cited by 32
Therapeutic Strategies for Restoring Tau HomeostasisPreprint
Young, Z. T., Mok, S., & Gestwicki, J. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 31
Protein aggregation and prionopathies
Renner, M. L., & Melki, R. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.01.003 · Cited by 31
The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis
Hanspal, M. A., Dobson, C. M., Yerbury, J. J., & Kumita, J. R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.007 · Cited by 30
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells
Primio, C. D., Quercioli, V., Siano, G., Rovere, M., Kováčech, B., Novák, M., & Cattaneo, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00210 · Cited by 30
P62 accumulates through neuroanatomical circuits in response to tauopathy propagation
de Thé, F.-X. B., Lassus, B., Schaler, A. W., Fowler, S. L., Goulbourne, C. N., Jeggo, R., la Cour, C. M., Millan, M. J., & Duff, K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01280-w · Cited by 28
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
Thal, D. R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00025 · Cited by 28
Liquid-Liquid Phase Separation of Tau Protein in Neurobiology and Pathology
Wegmann, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_25 · Cited by 28
The Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations
Wales, R. M., & Leung, H.-C. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0902 · Cited by 26
Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models
Song, H.-L., Kim, N.-Y., Park, J., Kim, M. I., Jeon, Y.-N., Lee, S.-J., Cho, K., Shim, Y.-L., Lee, K.-H., Mun, Y.-S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci156537 · Cited by 26
Impairment of entorhinal cortex network activity in Alzheimer’s disease
Karimani, F., Taei, A. A., Abolghasemi-Dehaghani, M.-R., Safari, M.-S., & Dargahi, L. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1402573 · Cited by 27
Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations
Meyer, V., Holden, M. R., Weismiller, H. A., Eaton, G. R., Eaton, S. S., & Margittai, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715557 · Cited by 26
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Fonseca, C., Ettcheto, M., Bicker, J., Fernandes, M. J., Falcão, A. C., Camins, A., & Fortuna, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101998 · Cited by 31
Visualization of prion-like transfer in Huntington's disease models
Jansen, A. H. P., Batenburg, K. L., Pecho‐Vrieseling, E., & Reits, E. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.015 · Cited by 26
Layer-specific expression of extracellular matrix molecules in the mouse somatosensory and piriform cortices
Ueno, H., Suemitsu, S., Murakami, S., Kitamura, N., Wani, K., Matsumoto, Y., Okamoto, M., & Ishihara, T. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.11.006 · Cited by 26
Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench
Franz, C. K., Joshi, D., Daley, E. L., Grant, R. A., Dalamagkas, K., Leung, A., Finan, J. D., & Kiskinis, E. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00572.2018 · Cited by 26
Tau in the brain interstitial fluid is fragmented and seeding–competent
Barini, E., Plotzky, G., Mordashova, Y., Hoppe, J., Rodriguez-Correa, E., Julier, S., Prieult, F. L., Mairhofer, I., Mezler, M., Biesinger, S., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.013 · Cited by 28

Authors: Kfoury, N., Holmes, B. B., Jiang, H., Holtzman, D. M., & Diamond, M. I.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Diamond, Marc I.
ORCID: Kfoury, Najla
Holmes, Brandon B.
Jiang, Hong
Holtzman, David M.
Diamond, Marc I.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2012-06
Volume: 287
Issue: 23
Pages: 19440-19451
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m112.346072
PMC: PMC3365982
OpenAlex: W2032355167
Cited by: 552
References: 43
Citations by year: 2026: 11 · 2025: 22 · 2024: 18 · 2023: 29 · 2022: 34 · 2021: 51 · 2020: 47 · 2019: 59 · 2018: 48 · 2017: 46 · 2016: 41 · 2015: 41 · 2014: 47 · 2013: 43 · 2012: 15
FWCI: 31.29
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 3025 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: American Health Assistance Foundation
Ruth K. Broad Biomedical Research Foundation
Muscular Dystrophy Association
Washington University in St. Louis
Foundation for Barnes-Jewish Hospital
Alvin J. Siteman Cancer Center
Hope Center for Neurological Disorders
National Institutes of Health (NS057105)
Tau Consortium
Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis
National Institute on Aging (P50AG005681)
National Institute of Neurological Disorders and Stroke (F31NS079039, P30NS057105, NS057105, R01NS071835)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: tau aggregation, Alzheimer's disease, frontotemporal dementia, protein misfolding, prion-like propagation, protein-protein contacts, neurodegenerative diseases
MeSH terms: Alzheimer Disease, Humans, Models, Biological, tau Proteins, Protein Folding, Multiprotein Complexes, Antibodies, Neutralizing, Frontotemporal Dementia, HEK293 Cells, Antibodies, Monoclonal, Murine-Derived

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trans-cellular Propagation of Tau Aggregation by Fibrillar Species

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks